• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非随机研究的证据:因果效应估计的案例研究

Evidence from nonrandomized studies: a case study on the estimation of causal effects.

作者信息

Schmoor Claudia, Caputo Angelika, Schumacher Martin

机构信息

Clinical Trials Center, University Medical Center Freiburg, Freiburg, Germany.

出版信息

Am J Epidemiol. 2008 May 1;167(9):1120-9. doi: 10.1093/aje/kwn010. Epub 2008 Mar 11.

DOI:10.1093/aje/kwn010
PMID:18334500
Abstract

Although randomized controlled trials are regarded as the gold standard for comparison of treatments, evidence from observational studies is still relevant. To cope with the problem of possible confounding in these studies, investigators need methods for analyzing their results which adjust for confounders and lead to unbiased estimation of the treatment effect. In this paper, the authors describe the main principles of three statistical methods for doing this. The first method is the classical approach of a multiple regression model including the effects of treatment and covariates. This considers the relation between prognostic factors and the outcome variable as a relevant criterion for adjustment. The second method is based on the propensity score, focusing on the relation between prognostic factors and treatment assignment. The third method is an ecologic approach using a grouped treatment variable, which may aid in avoiding confounding by indication. These approaches are applied to a partially randomized trial conducted in 720 German breast cancer patients between 1984 and 1997. The study had a comprehensive cohort study design that included recruitment of patients who had consented to participation but not to randomization because of a preference for one of the treatments. This design offers a unique opportunity to contrast results from the nonrandomized portion of a study with those for a randomized subcohort as a reference.

摘要

尽管随机对照试验被视为治疗比较的金标准,但观察性研究的证据仍然具有相关性。为了应对这些研究中可能存在的混杂问题,研究人员需要能够分析结果的方法,这些方法要对混杂因素进行调整,并能无偏估计治疗效果。在本文中,作者描述了三种用于此目的的统计方法的主要原理。第一种方法是多元回归模型的经典方法,包括治疗和协变量的效应。这将预后因素与结果变量之间的关系视为调整的相关标准。第二种方法基于倾向得分,侧重于预后因素与治疗分配之间的关系。第三种方法是一种生态方法,使用分组治疗变量,这可能有助于避免指征性混杂。这些方法应用于1984年至1997年间在720名德国乳腺癌患者中进行的一项部分随机试验。该研究采用了全面的队列研究设计,包括招募那些因偏爱其中一种治疗方法而同意参与但不同意随机分组的患者。这种设计提供了一个独特的机会,将研究中非随机部分的结果与作为参考的随机子队列的结果进行对比。

相似文献

1
Evidence from nonrandomized studies: a case study on the estimation of causal effects.非随机研究的证据:因果效应估计的案例研究
Am J Epidemiol. 2008 May 1;167(9):1120-9. doi: 10.1093/aje/kwn010. Epub 2008 Mar 11.
2
Correction of confounding bias in non-randomized studies by appropriate weighting.通过适当加权校正非随机研究中的混杂偏倚。
Biom J. 2011 Mar;53(2):369-87. doi: 10.1002/bimj.201000154. Epub 2011 Feb 10.
3
Sample size calculations for the two-sample problem using the multiplicative intensity model.使用乘法强度模型进行两样本问题的样本量计算。
Stat Med. 2001 Feb 28;20(4):557-79. doi: 10.1002/sim.693.
4
What random assignment does and does not do.随机分配的作用与局限。
J Clin Psychol. 2003 Jul;59(7):751-66. doi: 10.1002/jclp.10170.
5
Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.绝经前淋巴结阳性乳腺癌患者辅助性环磷酰胺、甲氨蝶呤和氟尿嘧啶治疗:丹麦乳腺癌协作组(DBCG)77、82和89号试验中剂量与方案的间接比较
Acta Oncol. 2008;47(4):662-71. doi: 10.1080/02841860801989761.
6
Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.两阶段工具变量法估计因果比值:偏倚分析。
Stat Med. 2011 Jul 10;30(15):1809-24. doi: 10.1002/sim.4241. Epub 2011 Apr 15.
7
Addressing the issue of channeling bias in observational studies with propensity scores analysis.用倾向得分分析解决观察性研究中的渠道偏差问题。
Res Social Adm Pharm. 2006 Mar;2(1):143-51. doi: 10.1016/j.sapharm.2005.12.001.
8
DBCG trial 89B comparing adjuvant CMF and ovarian ablation: similar outcome for eligible but non-enrolled and randomized breast cancer patients.比较辅助性CMF方案与卵巢去势的丹麦乳腺癌协作组试验89B:符合条件但未入组及随机分组的乳腺癌患者的结局相似。
Acta Oncol. 2008;47(4):709-17. doi: 10.1080/02841860802001475.
9
Methods to adjust for bias and confounding in critical care health services research involving observational data.在涉及观察性数据的重症监护健康服务研究中调整偏倚和混杂因素的方法。
J Crit Care. 2006 Mar;21(1):1-7. doi: 10.1016/j.jcrc.2006.01.004.
10
On the causal structure of information bias and confounding bias in randomized trials.关于随机试验中信息偏倚和混杂偏倚的因果结构。
J Eval Clin Pract. 2009 Dec;15(6):1214-6. doi: 10.1111/j.1365-2753.2009.01347.x.

引用本文的文献

1
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials: a meta-epidemiological study.采用观察性研究设计评估的医疗保健结果与采用随机试验评估的结果比较:一项meta 流行病学研究。
Cochrane Database Syst Rev. 2024 Jan 4;1(1):MR000034. doi: 10.1002/14651858.MR000034.pub3.
2
Evaluation of instrumental variable method using Cox proportional hazard model in epidemiological studies.在流行病学研究中使用Cox比例风险模型评估工具变量法。
MethodsX. 2023 May 11;10:102211. doi: 10.1016/j.mex.2023.102211. eCollection 2023.
3
Impact of investigator initiated trials and industry sponsored trials on medical practice (IMPACT): rationale and study design.
研究者发起的试验和工业界资助的试验对医疗实践的影响(IMPACT):原理和研究设计。
BMC Med Res Methodol. 2020 Oct 2;20(1):246. doi: 10.1186/s12874-020-01125-5.
4
Health Care Utilization and Treatment Persistence Associated with Oral Paliperidone and Lurasidone in Schizophrenia Treatment.精神分裂症治疗中口服帕利哌酮和鲁拉西酮与医疗保健利用和治疗持续性的关系。
J Manag Care Spec Pharm. 2015 Sep;21(9):780-92. doi: 10.18553/jmcp.2015.21.9.780.
5
Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials.与随机试验中评估的医疗保健结果相比,观察性研究设计评估的医疗保健结果。
Cochrane Database Syst Rev. 2014 Apr 29;2014(4):MR000034. doi: 10.1002/14651858.MR000034.pub2.
6
Using multiple types of studies in systematic reviews of health care interventions--a systematic review.系统评价医疗干预措施中使用多种类型的研究——系统评价。
PLoS One. 2013 Dec 26;8(12):e85035. doi: 10.1371/journal.pone.0085035. eCollection 2013.
7
How to optimize the evaluation and use of antibiotics in neonates.如何优化新生儿抗生素的评估和使用。
Pediatr Clin North Am. 2012 Oct;59(5):1117-28. doi: 10.1016/j.pcl.2012.07.004. Epub 2012 Sep 1.
8
Possible protective effect of hydroxychloroquine on delaying the occurrence of integument damage in lupus: LXXI, data from a multiethnic cohort.羟氯喹可能对延缓狼疮患者皮肤损伤的发生具有保护作用:LXXI,多民族队列的数据。
Arthritis Care Res (Hoboken). 2010 Mar;62(3):393-400. doi: 10.1002/acr.20097.
9
Instrumental variable methods in comparative safety and effectiveness research.工具变量法在比较安全性和有效性研究中的应用。
Pharmacoepidemiol Drug Saf. 2010 Jun;19(6):537-54. doi: 10.1002/pds.1908.
10
Patterns of care for early stage bladder cancer.早期膀胱癌的治疗模式。
Cancer. 2010 Jun 1;116(11):2604-11. doi: 10.1002/cncr.25007.